Discipline | Pharmacology, Biotechnology |
---|---|
Language | English |
Edited by | Peter Kirkpatrick |
Publication details | |
History | 2002–present |
Publisher | Nature Portfolio |
Frequency | Monthly |
Impact factor | 120.1 (2022) |
Standard abbreviations ISO 4 (alt) · Bluebook (alt) NLM (alt) · MathSciNet (alt ) | |
ISO 4 | Nat. Rev. Drug Discov. |
Indexing CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus | |
CODEN | NRDDAG |
ISSN | 1474-1776 (print) 1474-1784 (web) |
LCCN | 2002243044 |
OCLC no. | 427380493 |
Links | |
Nature Reviews Drug Discovery is a monthly peer-reviewed review journal published by Nature Portfolio. It was established in 2002 and covers drug discovery and development. The editor-in-chief is Peter Kirkpatrick. According to the Journal Citation Reports, the journal has a 2021 impact factor of 112.288, ranking it 1st out of 158 journals in the category "Biotechnology & Applied Microbiology" and 1st out of 279 journals in the category "Pharmacology & Pharmacy".
Reviews are commissioned to specialists and supplemented with glossary explanations for non-specialist readers and illustrated with figures drawn by Nature's in-house art editors. Besides reviews, the journal publishes analysis articles based on existing datasets (e.g. metaanalysis), progress articles that focus on outstanding issues, and perspective articles—typically opinions or historical pieces.
See also
References
- "Displaying Record for Publication: Nature Reviews Drug Discovery". CASSI. Chemical Abstracts Service. Retrieved 2022-08-09.
- "About the Editors". nature.com. Springer Nature. Retrieved 2022-08-09.
- "Journals Ranked by Impact: Biotechnology & Applied Microbiology". 2021 Journal Citation Reports. Web of Science (Science ed.). Clarivate. 2022.
- "Journals Ranked by Impact: Pharmacology & Pharmacy". 2021 Journal Citation Reports. Web of Science (Science ed.). Clarivate. 2022.
- Guide : Information : Nature Reviews Drug Discovery. Nature.com. Retrieved on 2011-06-29.
External links
Holtzbrinck Publishing Group | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Holtzbrinck |
| ||||||||||||
Macmillan |
| ||||||||||||
Springer Nature (53%) |
This article about a pharmacology journal is a stub. You can help Misplaced Pages by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |